{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:26:14Z","timestamp":1793381174298,"version":"4.5.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,2,23]]},"abstract":"<jats:p>Oily skin and acne vulgaris are prevalent dermatological conditions with a significant impact on both physical and emotional well-being. Despite numerous available treatments, there is a pressing need for effective, long-term solutions. Botulinum Neurotoxin (BoNT-A) has emerged as a potential therapeutic option. However, existing reviews in this area are often limited. This review aims to comprehensively assess the use of BoNT-A in managing oily skin and acne vulgaris while addressing gaps in previous publications. It integrates the latest research, clinical trials, and case studies to provide an up-to-date analysis of BoNT-A mechanisms of action, efficacy, safety, and long-term outcomes. The review systematically analyzes existing evidence, critically evaluates study strengths and limitations, and explores potential synergies with other treatments. It also examines the safety profile of BoNT-A and its potential long-term effects. This review uncovers promising insights into how BoNT-A affects oily skin and acne vulgaris, including its ability to regulate sebum production, reduce inflammation, and potentially shrink pore size. It provides a comprehensive overview of relevant studies and clinical trials, detailing their methodologies, protocols, measures, and results. Collectively, these studies show significant reductions in sebum production, increased patient satisfaction, and smaller pores following BoNT-A treatment. In conclusion, this review addresses knowledge gaps and provides a comprehensive analysis of BoNT-A as a therapeutic option for oily skin and acne vulgaris. By consolidating evidence and highlighting areas for further investigation, it guides clinicians and researchers toward more effective, personalized treatments for individuals with these dermatological challenges.<\/jats:p>","DOI":"10.1097\/md.0000000000037208","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T21:06:52Z","timestamp":1708722412000},"page":"e37208","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["The role of botulinum neurotoxin BoNT-A in the management of oily skin and acne vulgaris: A comprehensive review"],"prefix":"10.1097","volume":"103","author":[{"given":"Salman Bin","family":"Dayel","sequence":"first","affiliation":[{"name":"Department of Dermatology, College of Medicine, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3620-0648","authenticated-orcid":false,"given":"Ramadan S.","family":"Hussein","sequence":"additional","affiliation":[{"name":"Department of Dermatology, College of Medicine, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huda H.","family":"Gafar","sequence":"additional","affiliation":[{"name":"Clinical Pathology Department, College of Medicine, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1477-7525-6-80","article-title":"Patient experiences with oily skin: the qualitative development of content for two new patient-reported outcome questionnaires.","volume":"6","author":"Arbuckle","year":"2008","journal-title":"Health Qual Life Outcomes"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/dsu.12097","article-title":"Safety and efficacy of intradermal injection of botulinum toxin for the treatment of oily skin.","volume":"39","author":"Rose","year":"2013","journal-title":"Dermatol Surg"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1365-2133.1985.tb15265.x","article-title":"Measurement of sebum excretion rate and skin temperature above and below the neurological lesion in paraplegic patients.","volume":"112","author":"Thomas","year":"1985","journal-title":"Br J Dermatol"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1590\/abd1806-4841.20187437","article-title":"Unilateral acne after facial palsy.","volume":"93","author":"Sudy","year":"2018","journal-title":"An Bras Dermatol"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/jocd.12866","article-title":"Efficacy and possible mechanisms of botulinum toxin treatment of oily skin.","volume":"18","author":"Shuo","year":"2019","journal-title":"J Cosmet Dermatol"},{"key":"R6-20250503","first-page":"49","article-title":"Oily skin: a review of treatment options.","volume":"10","author":"Endly","year":"2017","journal-title":"J Clin Aesthet Dermatol"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jdermsci.2013.06.009","article-title":"Regulation of lipid production by acetylcholine signaling in human sebaceous glands.","volume":"72","author":"Li","year":"2013","journal-title":"J Dermatol Sci"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000083259","article-title":"Botulinum toxin: mechanisms of action.","volume":"53","author":"Dressler","year":"2005","journal-title":"Eur Neurol"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1600-0625.2008.00725.x","article-title":"Frontiers in sebaceous gland biology and pathology.","volume":"17","author":"Zouboulis","year":"2008","journal-title":"Exp Dermatol"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/1523-1747.ep12613582","article-title":"Keratinocyte muscarinic acetylcholine receptors: immunolocalization and partial characterization.","volume":"104","author":"Grando","year":"1995","journal-title":"J Invest Dermatol"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.molmed.2020.09.002","article-title":"Translational neuroendocrinology of human skin: concepts and perspectives.","volume":"27","author":"Ramot","year":"2021","journal-title":"Trends Mol Med"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/exd.14173","article-title":"Targeting the \u03b17 nicotinic acetylcholine receptor\u2014a novel road towards the future treatment of skin diseases.","volume":"29","author":"Stegemann","year":"2020","journal-title":"Exp Dermatol"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.0022-202X.2004.23425.x","article-title":"Phenotypical and molecular profiling of the extraneuronal cholinergic system of the skin.","volume":"123","author":"Kurzen","year":"2004","journal-title":"J Invest Dermatol"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0625.2004.00258.x","article-title":"Novel aspects in cutaneous biology of acetylcholine synthesis and acetylcholine receptors.","volume":"13","author":"Kurzen","year":"2004","journal-title":"Exp Dermatol"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1517\/13543784.2014.923401","article-title":"Novel pharmacological approaches for the treatment of acne vulgaris.","volume":"23","author":"Valente Duarte De Sousa","year":"2014","journal-title":"Expert Opin Investig Drugs"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/ijd.15574","article-title":"The effectiveness of botulinum toxin type A (BTX-A) in the treatment of facial skin oily seborrhea, enlarged pores, and symptom complex of post-acne.","volume":"60","author":"Shirshakova","year":"2021","journal-title":"Int J Dermatol"},{"key":"R18-20250503","first-page":"847","article-title":"Use of intradermal botulinum toxin to reduce sebum production and facial pore size.","volume":"7","author":"Shah","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1473-2165.2006.00250.x","article-title":"Botulinum toxin in dermatology\u2014beyond wrinkles and sweat.","volume":"5","author":"Diamond","year":"2006","journal-title":"J Cosmet Dermatol"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/asj\/sju150","article-title":"Sebum production alteration after botulinum toxin type A injections for the treatment of forehead rhytides: a prospective randomized double-blind dose-comparative clinical investigation.","volume":"35","author":"Min","year":"2015","journal-title":"Aesthet Surg J"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neuroscience.2017.06.040","article-title":"Involvement of substance P in the antinociceptive effect of botulinum toxin type A: evidence from knockout mice.","volume":"358","author":"Matak","year":"2017","journal-title":"Neuroscience"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/WNF.0b013e31815cba8a","article-title":"Undesirable distant effects following botulinum toxin type A injection.","volume":"31","author":"Roche","year":"2008","journal-title":"Clin Neuropharmacol"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.toxicon.2010.12.019","article-title":"Studies on the dissociation of botulinum neurotoxin type A complexes.","volume":"57","author":"Eisele","year":"2011","journal-title":"Toxicon"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/WNF.0b013e3181d479e0","article-title":"Iatrogenic botulism after botulinum toxin type A injections.","volume":"33","author":"Coban","year":"2010","journal-title":"Clin Neuropharmacol"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/WNF.0b013e3181f5329e","article-title":"Systemic weakness after therapeutic injections of botulinum toxin A: a case series and review of the literature.","volume":"33","author":"Crowner","year":"2010","journal-title":"Clin Neuropharmacol"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"e000646","DOI":"10.1136\/bmjopen-2011-000646","article-title":"Prospective analysis of neutralizing antibody titres in secondary non-responders under continuous treatment with a botulinum toxin type A preparation free of complexing proteins\u2013a single cohort 4-year follow-up study.","volume":"2","author":"Hefter","year":"2012","journal-title":"BMJ Open"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1006\/exnr.1997.6580","article-title":"Botulinum toxin A therapy: neutralizing and non-neutralizing antibodies\u2014therapeutic consequences.","volume":"147","author":"G\u00f6schel","year":"1997","journal-title":"Exp Neurol"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2147\/CCID.S402001","article-title":"Combined treatment with micro-focused ultrasound with visualization and intradermal incobotulinumtoxin-A for enlarged facial pores: a retrospective study in Asians.","volume":"16","author":"Park","year":"2023","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"e12781","DOI":"10.1111\/dth.12781","article-title":"Intralesional triamcinolone alone or in combination with botulinum toxin A is ineffective for the treatment of formed keloid scar: a double-blind controlled pilot study.","volume":"32","author":"Rasaii","year":"2019","journal-title":"Dermatol Ther"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3390\/toxins13110817","article-title":"Botulinum neurotoxin type A in the treatment of facial seborrhea and acne: evidence and a proposed mechanism.","volume":"13","author":"Rho","year":"2021","journal-title":"Toxins (Basel)"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"e15205","DOI":"10.1111\/dth.15205","article-title":"Emerging off-label esthetic uses of botulinum toxin in dermatology.","volume":"35","author":"Phan","year":"2022","journal-title":"Dermatol Ther"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037208","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:33:30Z","timestamp":1746318810000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,23]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037208","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,23]]}}}